Navigation Links
UCB Presents Long-Term CImzia Data in Crohn's Disease

Cimzia Maintained Long-term Response at Stable Doses, According to New Data Presented at Digestive Disease Week (DDW)

ATLANTA, May 22, 2007 /PRNewswire/ -- UCB announced today that new data presented at Digestive Disease Week 2007 (DDW) demonstrated long-term response and remission in Crohn's disease patients treated with Cimzia (certolizumab pegol), the only Fc-free PEGylated, Fab' fragment anti-TNF.

The study, called PRECiSE 3 (P3), is a long-term open label continuation of the Phase III PRECiSE Program for CIMZIA(TM). Some of the study results presented at DDW are an interim analysis of a patient subgroup that responded continuously to CIMZIA(TM) during an 18-month period. These patients completed the PRECiSE 1 (P1) or PRECiSE 2 (P2) trials, enrolling in P3 at week 26. At week 80, the study showed that more than 85 percent of the patient subgroup who continuously received CIMZIA(TM) 400 mg subcutaneously every four weeks maintained clinical response, with nearly 74 percent of these patients achieving remission. (1) The extension study used the Harvey-Bradshaw Index (HBI)(a) to assess clinical response (defined as a reduction in HBI score of at least three points) and remission (HBI score less than or equal to four points).

Importantly, results reported from P3 indicated that CIMZIA(TM) was well- tolerated throughout the study. The percentage of patients experiencing injection-site reactions and injection-site pain was low (<2%, <1% respectively). (3)

"These study results show robust rates of clinical response and remission during an 18-month period in patients with Crohn's disease," said Stephen Hanauer, M.D., Professor of Medicine and Clinical Pharmacology Chief, Section of Gastroenterology and Nutrition, University of Chicago, and study co-author. "Also, CIMZIA(TM) dosing did not need to be increased over the course of the study."

"These results fortify UCB's commitment to obtai
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
3. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
4. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
5. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
6. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
7. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
8. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
9. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
10. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
11. BioCryst Presents Phase I Peramivir Data at the Options for the Control of Influenza Conference
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: UCB Presents Long Term CImzia Data Crohn Disease
(Date:8/29/2014)... , August 29, 2014 Pixcelldata, ... collaboration software has announced a major new deal with ... by renowned pathology expert, Dr. Marius Nap . ... the 26th European Congress of Pathology which is taking ... ExCeL Arena, London where Pixcelldata ...
(Date:8/28/2014)... WILMINGTON, Del. , Aug. 28, 2014  Rigrodsky & Long, ... shares of Lannett Company, Inc. (NYSE: LCI )? , ... between September 10, 2013 and July 16, 2014, inclusive? , ... Inc.? , Do you want to discuss your rights? ... former Special Assistant United States Attorney, Timothy J. MacFall , ...
(Date:8/28/2014)... 28, 2014  Decision Resources Group finds that ... strongly through 2022 at a compound annual growth ... largely supported by strong population growth and a ... imaging procedures. The Indian government,s greater investment in ... purchase or upgrade diagnostic imaging equipment. ...
Breaking Medicine Technology:Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 3Indian Diagnostic Imaging System Market Will Grow at 6 Percent Annually Through 2022 2Indian Diagnostic Imaging System Market Will Grow at 6 Percent Annually Through 2022 3
... NEW YORK, Dec. 2 Keryx Biopharmaceuticals, Inc. (Nasdaq: ... and Drug Administration (FDA) has granted Fast Track designation ... anti-cancer agent that inhibits the phosphoinositide 3-kinase (PI3K)/Akt pathway, ... , The Fast Track program of the FDA is ...
... BIRMINGHAM, Ala., Dec. 2 Adults are more likely to ... over, the odds of losing vision are one in three, whereas the ... odds of a woman developing breast cancer are one in nine. ... risk of injuries, depression and inability to complete daily tasks. , Vision ...
Cached Medicine Technology:Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 2Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 3Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 4Risk of Vision Loss in Aging Adults is Greater Than Risk of Breast or Prostate Cancer 2
(Date:8/29/2014)... Grove Village, IL (PRWEB) August 29, 2014 ... Kathleen Baty, “The Safety Chick” who profiled a ... ETY•Kids® Safe-Listening Earphones from Etymotic Research. This year, ... supply list, and Etymotic, an innovator of hearing ... young ears. Their ETY•Kids Safe-Listening Earphones, offered in ...
(Date:8/29/2014)... The microbiology testing sector is one of the ... is also the hugest challenge facing suppliers during these ... of AIDS – still the world’s key health threat ... opportunistic infections (OIs); bioterrorism threat; advancements in technologies for ... Although for certain infections the etiology remains a mystery, ...
(Date:8/29/2014)... Virginia Beach, VA (PRWEB) August 29, 2014 ... of the top ten tools for online teaching, as ... Award for Best Course or Learning Management System, announced ... Center of America, Metis Leadership Group, Interactive Advertising Bureau ... to the user community. , “We are delighted to ...
(Date:8/29/2014)... August 30, 2014 Top10inaction, a professional ... conference providers in the online service industry for the ... global leaders Webex, GotoMeeting and Infinite. , With over ... have to determine which provider is ideally a good ... businesses search for compelling consumer goods and services agencies ...
(Date:8/29/2014)... 29, 2014 After having a double ... had to have breast reconstruction. She found that the ... she decided that there needed to be a solution. ... a woman or man who needs or wants breast ... promotes confidence and peace of mind. Producible in design ...
Breaking Medicine News(10 mins):Health News:The Today Show Features ETY•Kids® Safe-Listening Earphones by Etymotic 2Health News:Infectious Disease Testing Universe Examined in New VPG Research Report Available at MarketPublishers.com 2Health News:Infectious Disease Testing Universe Examined in New VPG Research Report Available at MarketPublishers.com 3Health News:Edvance360 Continues to Experience Growth in Corporate, K-12, Health, and Non-Profit Sectors 2Health News:Top10InAction Reveals Best Web Conference Providers 2
... are conducted periodically to check fitness in students. Jack ... year's results of the annual assessment of fifth, seventh ... the fifth, seventh and ninth graders and studies student ... the test this year. Only one-third could meet the ...
... dangerous information available on the internet is causing eating ... // ,The NHS Quality Improvement Scotland (NHS ... have been increasing the dangers faced by thousands of ... ,The first ever guidelines have been issued ...
... attacks are less likely to have properly managed the ... quality of life, a new study finds. ... Health Cooperative in Seattle, said her group's previous work ... more diabetes symptom, and lower functioning. 'But because panic ...
... ON HEART IN CHILDREN // ,For children, even mild ... enlargement of the heart, according to results of a study ... Children's Hospital at Montefiore in Bronx, New York. ... higher the blood pressure the worse the strain on the ...
... UK opine that new measures have to be considered to ... comprehensive immunization from the health officials in India, almost one-third ... ,According to the experts in UK, the ... to improper sanitation and congestion of living space. These obstacles ...
... that he proposed to introduce a bill that would ... bill is better known as "Texas Smoke-Free Workplace Law." ... be banned under legislation. ,Ellis made his announcement on the ... Great American Smokeout. ,"Even though cities all over ...
Cached Medicine News:Health News:Internet Health Advice Causing More Harm than Good 2Health News:Panic Attacks Can Increase Complications in Diabetes Patients 2Health News:Children and Chronic Kidney Disease 2Health News:Children and Chronic Kidney Disease 3Health News:Polio can be eradicated in India: Health Experts 2
... an affordable solution for low volume workloads, ... menu includes a variety of clotting assays, ... ACL 1000 also offers bar code capability ... Plus, it's backed by superior technology that ...
... workstation offers a broad menu, ... the mid-size lab that processes ... day. Like all SYNCHRON CX-S ... to use, easy to maintain ...
... way to improve your laboratory's testing process, ... menu profiler eliminates time-consuming manual processes and ... Plus, the CX9 PRO performs a comprehensive ... DATs, proteins and serologies -- and provides ...
When it comes to providing speed, accuracy and menu flexibility, the SYNCHRON CX5 PRO has it all. The state-of-the-art CX5 PRO starts with the wide SYNCHRON chemistry menu to create the ideal full-se...
Medicine Products: